Novartis chases rivals with next wave of cancer immunotherapy

(Reuters) - Novartis , lagging some other big drugmakers in the first wave of immunotherapy drugs that are revolutionizing cancer treatment, hopes to catch up by focusing on the next wave of immune system-boosting medicines.